ABT Company Profile and Key Details
Abbott Laboratories
ABT Stock Price Chart
Stock Price Today
Abbott Laboratories (ABT) stock surged +0.85%, trading at $117.78 on NYSE, up from the previous close of $116.79. The stock opened at $114.13, fluctuating between $113.50 and $119.94 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Company Information
| Employees | 114000 |
| Beta | 0.72 |
| Sales or Revenue | $40.11B |
| 5Y Sales Change% | 0.328% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Abbott Laboratories (NYSE: ABT) stock price is $117.78 in the last trading session. During the trading session, ABT stock reached the peak price of $119.94 while $113.50 was the lowest point it dropped to. The percentage change in ABT stock occurred in the recent session was 0.85% while the dollar amount for the price change in ABT stock was $0.99.
The NYSE listed ABT is part of Medical - Devices industry that operates in the broader Healthcare sector. Abbott Laboratories designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Joseph J. Manning
Executive Vice President of Nutritional Products
Mr. Scott Michael Leinenweber
SVice President of Licensing, Acquisitions & Ventures
Ms. Elaine R. Leavenworth
Senior Vice President and Chief Marketing & External Affairs Officer
James E. Young
Vice President and Chief Ethics & Compliance Officer
Dr. John M. Capek
Executive Vice President of Ventures
Mr. Robert B. Ford
Chairman, Pres & Chief Executive Officer
Mr. Robert E. Funck Jr.
Executive Vice President of Fin. & Chief Financial Officer
Mr. Hubert L. Allen
Executive Vice President, Gen. Counsel & Sec.
Ms. Andrea F. Wainer
Executive Vice President of Rapid & Molecular Diagnostics
Erica L. Battaglia
Vice President and Chief Ethics & Compliance Officer
Ms. Melissa Brotz
Vice President of Public Affairs & Corporation Marketing
Ms. Mary K. Moreland
Executive Vice President of HR
Mr. Jared L. Watkin
Senior Vice President of Diabetes Care
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group Pres of Established Pharmaceuticals & Nutritional Products
ABT's closing price is 18.12% higher than its 52-week low of $99.71 where as its distance from 52-week high of $121.64 is -3.17%.
Number of ABT employees currently stands at 114,000.
Official Website of ABT is: https://www.abbott.com
ABT could be contacted at phone 224 667 6100 and can also be accessed through its website. ABT operates from 100 Abbott Park Road, North Chicago, IL 60064-6400, United States.
ABT stock volume for the day was 13.15M shares. The average number of ABT shares traded daily for last 3 months was 5.04M.
The market value of ABT currently stands at $204.28B with its latest stock price at $117.78 and 1.73B of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com